Treatment Approaches for Multiple Sclerosis Patients

This research brief analyzes the treatment approaches for multiple sclerosis (MS) patients, focusing on escalation and induction strategies for disease-modifying therapies (DMTs). The study utilizes Komodo’s Healthcare Map to assess treatment patterns among approximately 930,000 patients with MS claims from January 2016 to June 2023. It finds that both escalation and induction approaches are utilized nearly equally, with 48% of patients undergoing escalation and 52% induction. The analysis highlights that patients on an escalation regime often remain on lower-efficacy drugs for extended periods, while those on induction therapy are more likely to be commercially insured and male. The brief discusses the implications of these findings, noting that treatment decisions are influenced by various factors, including provider education and socioeconomic disparities. It emphasizes the need for ongoing research to refine treatment guidelines and improve patient outcomes, particularly as the understanding of MS treatment evolves.